138 related articles for article (PubMed ID: 19728907)
1. [Multivariate analysis of clinicopathologic factors correlated with pathological complete response following preoperative radiotherapy in rectal adenocarcinoma].
Lin JZ; Pan ZZ; Zeng ZF; Ding PR; Wan DS
Ai Zheng; 2009 Sep; 28(9):919-22. PubMed ID: 19728907
[TBL] [Abstract][Full Text] [Related]
2. [Risk factors related to lymph node metastases after neoadjuvant therapy for locally advanced rectal cancer].
Zeng ZF; Ding PR; Pan ZZ; Lin JZ; Li LR; Lu ZH; Wu XJ; Kong LH; Zhou ZG; Wan DS
Ai Zheng; 2009 Sep; 28(9):923-7. PubMed ID: 19728908
[TBL] [Abstract][Full Text] [Related]
3. Predictors of sensitivity to preoperative chemoradiotherapy of rectal adenocarcinoma.
Yan H; Wang R; Zhu K; Zhao W; Jiang S; Feng R; Xu X; Meng X; Sun H; Zhang H; Mu D; Xu Z
Tumori; 2011; 97(6):717-23. PubMed ID: 22322837
[TBL] [Abstract][Full Text] [Related]
4. Complete pathologic response following preoperative chemoradiation therapy for middle to lower rectal cancer is not a prognostic factor for a better outcome.
Pucciarelli S; Toppan P; Friso ML; Russo V; Pasetto L; Urso E; Marino F; Ambrosi A; Lise M
Dis Colon Rectum; 2004 Nov; 47(11):1798-807. PubMed ID: 15622571
[TBL] [Abstract][Full Text] [Related]
5. Serum CEA as a predictor for the response to preoperative chemoradiation in rectal cancer.
Park YA; Sohn SK; Seong J; Baik SH; Lee KY; Kim NK; Cho CW
J Surg Oncol; 2006 Feb; 93(2):145-50. PubMed ID: 16425302
[TBL] [Abstract][Full Text] [Related]
6. [Clinical significance of a transient increase in carcinoembryonic antigen and carbohydrate antigen 19-9 in patients with metastatic colorectal cancer receiving chemotherapy].
Li YH; An X; Xiang XJ; Wang ZQ; Wang FH; Feng F; Jiang WQ; He YJ; Xu RH
Ai Zheng; 2009 Sep; 28(9):939-44. PubMed ID: 19728911
[TBL] [Abstract][Full Text] [Related]
7. A phase I/II trial of three-dimensionally planned concurrent boost radiotherapy and protracted venous infusion of 5-FU chemotherapy for locally advanced rectal carcinoma.
Myerson RJ; Valentini V; Birnbaum EH; Cellini N; Coco C; Fleshman JW; Gambacorta MA; Genovesi D; Kodner IJ; Picus J; Ratkin GA; Read TE
Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1299-308. PubMed ID: 11483342
[TBL] [Abstract][Full Text] [Related]
8. Phase II study of pre-operative radiotherapy with capecitabine and oxaliplatin for rectal cancer and carcinoembryonic antigen as a predictor of pathological tumour response.
Lin JZ; Zeng ZF; Wu XJ; Wan DS; Chen G; Li LR; Lu ZH; Ding PR; Pan ZZ
J Int Med Res; 2010; 38(2):645-54. PubMed ID: 20515578
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Value of Pretreatment Serum CA199 in Patients with Locally Advanced Rectal Cancer Treated with CRT Followed by TME with Normal Pretreatment Carcinoembryonic Antigen Levels.
Huang D; Lin Q; Song J; Xu B
Dig Surg; 2021; 38(1):24-29. PubMed ID: 33171467
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety-in analysis of short-course radiation followed by mFOLFOX-6 plus avelumab for locally advanced rectal adenocarcinoma.
Shamseddine A; Zeidan YH; El Husseini Z; Kreidieh M; Al Darazi M; Turfa R; Kattan J; Khalifeh I; Mukherji D; Temraz S; Alqasem K; Amarin R; Al Awabdeh T; Deeba S; Jamali F; Mohamad I; Elkhaldi M; Daoud F; Al Masri M; Dabous A; Hushki A; Jaber O; Charafeddine M; Geara F
Radiat Oncol; 2020 Oct; 15(1):233. PubMed ID: 33028346
[TBL] [Abstract][Full Text] [Related]
11. Identification of a biomarker profile associated with resistance to neoadjuvant chemoradiation therapy in rectal cancer.
Garcia-Aguilar J; Chen Z; Smith DD; Li W; Madoff RD; Cataldo P; Marcet J; Pastor C
Ann Surg; 2011 Sep; 254(3):486-92; discussion 492-3. PubMed ID: 21865946
[TBL] [Abstract][Full Text] [Related]
12. Pathologic complete response after FOLFOX7 in a locally advanced rectal cancer.
Li J; Rose MG; Perkal MF; Chao HH
J Clin Gastroenterol; 2012 Jan; 46(1):87-8. PubMed ID: 22157222
[No Abstract] [Full Text] [Related]
13. Predictive factors of tumor response after neoadjuvant chemoradiation for locally advanced rectal cancer.
Moureau-Zabotto L; Farnault B; de Chaisemartin C; Esterni B; Lelong B; Viret F; Giovannini M; Monges G; Delpero JR; Bories E; Turrini O; Viens P; Salem N
Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):483-91. PubMed ID: 21093174
[TBL] [Abstract][Full Text] [Related]
14. Clinical evaluation of CEA, CA19-9, CA72-4 and CA125 in gastric cancer patients with neoadjuvant chemotherapy.
Sun Z; Zhang N
World J Surg Oncol; 2014 Dec; 12():397. PubMed ID: 25543664
[TBL] [Abstract][Full Text] [Related]
15. Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial.
Hong YS; Nam BH; Kim KP; Kim JE; Park SJ; Park YS; Park JO; Kim SY; Kim TY; Kim JH; Ahn JB; Lim SB; Yu CS; Kim JC; Yun SH; Kim JH; Park JH; Park HC; Jung KH; Kim TW
Lancet Oncol; 2014 Oct; 15(11):1245-53. PubMed ID: 25201358
[TBL] [Abstract][Full Text] [Related]
16. Correlation of CEA but not CA 19-9 as serum biomarkers of disease activity in a case of metastatic rectal adenocarcinoma.
Marks EI; Brennan M; El-Deiry WS
Cancer Biol Ther; 2015; 16(8):1136-9. PubMed ID: 26047368
[TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant conformal chemoradiation with induction chemotherapy for rectal adenocarcinoma. A prospective observational study.
Fekete Z; Muntean AS; Hica Ş; Rancea A; Resiga L; Csutak C; Todor N; Nagy VM
J Gastrointestin Liver Dis; 2014 Jun; 23(2):171-8. PubMed ID: 24949609
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of pretreatment level of carcinoembryonic antigen on tumour downstaging and early occurring metastasis in locally advanced rectal cancer following neoadjuvant radiotherapy (30 Gy in 10 fractions).
Wang L; Zhong XG; Peng YF; Li ZW; Gu J
Colorectal Dis; 2014 Jan; 16(1):33-9. PubMed ID: 23848511
[TBL] [Abstract][Full Text] [Related]
19. Analyses of predictive factors for pathological complete remission in neoadjuvant therapy for locally advanced rectal cancer.
Yang J; Ling X; Tang W; Hu D; Zhou H; Yin G
J BUON; 2019; 24(1):77-83. PubMed ID: 30941954
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of preoperative radiation therapy for resectable rectal adenocarcinoma when combined with oral tegafur-uracil modulated with leucovorin: results from a phase II study.
Uzcudun AE; Batlle JF; Velasco JC; Sánchez Santos ME; Carpeño Jde C; Grande AG; Juberías AM; Piñeiro EH; Olivar LM; García AG
Dis Colon Rectum; 2002 Oct; 45(10):1349-58. PubMed ID: 12394434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
